Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.
Sign up for the Good Day BIO Newsletter >
June 3-6, 2024 | San Diego, CA
October 17-18, 2023 | San Francisco, CA
October 23-25, 2023 | Washington, DC
November 13-15, 2023 | New Orleans, LA
Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.
Our tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.
Bringing you daily news at the intersection of biotechnology, politics, patients & the planet.
David (Dave) Lawrence Chief Business Officer Neurotrauma Sciences, LLC. Alpharetta, GA
Mike Knievel Sr. Director, Procurement Gilead Sciences Foster City, CA
Robert Freeberg Senior Director, Procurement Sangamo Therapeutics, Inc. Richmond, CA
Michelle Charpentier Head of Tech Ops Global Procurement BioMarin Pharmaceutical Inc. Novato, CA
Lynn M. Cilinski Vice President, Controller & Treasurer MacroGenics, Inc. Rockville, MD
Nicol Godfrey Senior Manager, Procurement Five Prime Therapeutics, Inc. South San Francisco, CA
Pat Magnafichi Director, Procurement Exelixis Alameda, CA
Ryan StoeckelAssociate Director, Procurement at Verve Therapeutics Cambridge, MA
.png){kind=logo}
